Welcome to the October 2025 edition of the newsletter from the NSCLC Patient Gateway.
Since our last newsletter in April, we have seen a lot of progress in the non-small cell lung cancer (NSCLC) space across many aspects of patient care—including the FDA approval of an antibody-drug conjugate called telisotuzumab vedotin-tllv to treat patients with locally advanced or metastatic NSCLC with high levels of c-Met protein.
We are also developing a better understanding of how to treat NSCLC in the early stages of disease. Several studies are helping us understand how to use immunotherapy before and after surgery to treat NSCLC while maintaining the patients’ quality of life. In addition, researchers are learning more about when to choose radiation therapy compared to surgery to treat patients with stage 1 disease.
New types of treatments are also being developed. Researchers are particularly enthusiastic about bispecific antibodies, treatments that can target two elements, to kill tumor cells while leaving healthy cells unharmed.
Research continues to make tremendous progress for people living with NSCLC, providing paths for lifesaving breakthroughs.
You can explore more about the latest research from major lung cancer conferences in the “Have You Seen” section below."
.
Research News
FDA Approves Emrelis for High c-Met Protein Overexpressing NSCLC
Clinical Advisor
May 20, 2025
ASCO Updates Living Guidelines to Include New Treatment Strategies for NSCLC With/Without Driver Alterations
OncLive
August 7, 2025
SABR Ties With SOC Surgery in NSCLC Survival
Medscape
October 5, 2025
Bispecific antibodies offer new hope for resistant NSCLC patients
News-Medical.Net
June 23, 2025
Get Connected
Join Us for the NSCLC Virtual Meetup
This is an easy way to build your community. On the second Wednesday of each month, you can connect with others who understand what it’s like to live with NSCLC. The next NSCLC Meetup is happening on November 13, 2024, at 12 pm ET. Register for free for this virtual meetup to get a confirmation email with details about how to join the virtual meeting. New attendees are always welcome and encouraged to join!
Can’t make it? Don’t worry, there’s a full list of virtual meetups to fit your schedule.
Have You Seen?
Highlights from the Biggest Research Conferences
Throughout the year, LUNGevity brings you news from the most impactful oncology conferences so you can stay up to date on the progress and breakthroughs in lung cancer research and treatment. Check out our coverage from the recent World Conference on Lung Cancer and our summer coverage of the annual meeting of the American Society of Clinical Oncology. Stay tuned for upcoming highlights from the annual meeting of the European Society of Medical Oncology in Berlin, Germany.
Tips to Manage Scanxiety
Many people struggle with feelings of anxiety or worry before medical exams, such as an MRI or CT scans. LUNGevity has compiled six tips to help patients and caregivers manage this “scanxiety.” Learn more.
Why Do Some People Who’ve Never Smoked Get Lung Cancer?
Lung cancer in individuals who have never smoked (LCINS) is becoming more common. These people are often younger women with no history of tobacco exposure. Researchers are working to understand the needs of this growing population by identifying other risk factors for lung cancer, such as family history and environmental exposures. Learn more.
…and there is always so much more to explore on the NSCLC Patient Gateway.
If you were forwarded this email and you’d like to subscribe to this newsletter, you can sign up here.
If you are looking for more LUNGevity Foundation news, check out LUNGevity’s monthly newsletter.
If you need further assistance along your lung cancer journey, please email us at support@lungevity.org. Our team is always here to assist you.
